Reports for AA PHARMA INC
Company Name
AA PHARMA INC
Totals |
||
Shortage reports |
362 |
|
| Actual shortage: | 21 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (2%) | |
| Resolved: | 335 (93%) | |
Discontinuation Reports |
58 |
|
| To be discontinued: | 1 (2%) | |
| Discontinued: | 55 (95%) | |
| Reversed: | 2 (3%) | |
Late reports |
27 (6%) |
|
Overdue reports |
12 (55%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHAZOLAMIDE | 50MG | TABLET | Resolved | 2023-06-29 | 2023-08-03 | 196840 |
| METHAZOLAMIDE | 50MG | TABLET | Actual shortage | 2024-03-11 | 2024-04-11 | 221860 |
| MEGESTROL | 40MG | TABLET | Resolved | 2020-07-07 | 2020-07-24 | 119624 |
| MEGESTROL | 40MG | TABLET | Resolved | 2022-11-22 | 2022-11-29 | 175461 |
| MEGESTROL | 40MG | TABLET | Resolved | 2023-03-30 | 2023-08-23 | 188323 |
| MEFLOQUINE | 250MG | TABLET | Resolved | 2023-08-23 | 2023-09-14 | 202753 |
| MEFENAMIC | 250MG | CAPSULE | Resolved | 2021-07-08 | 2021-07-14 | 142026 |
| MEFENAMIC | 250MG | CAPSULE | Resolved | 2023-11-15 | 2024-01-31 | 210273 |
| LORAZEPAM SUBLINGUAL | 0.5MG | TABLET | Resolved | 2023-02-03 | 2023-04-17 | 183599 |
| LORAZEPAM SUBLINGUAL | 0.5MG | TABLET | Resolved | 2023-05-11 | 2023-07-15 | 192270 |
| LORAZEPAM SUBLINGUAL | 1MG | TABLET | Resolved | 2021-09-09 | 2021-09-30 | 145410 |
| LORAZEPAM SUBLINGUAL | 1MG | TABLET | Resolved | 2023-02-28 | 2023-05-01 | 185682 |
| LITHMAX | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-07 | 2024-01-20 | 212786 |
| LITHMAX | 300MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-11 | 2024-04-02 | 221857 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2018-07-17 | 2019-01-08 | 55999 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2018-07-19 | 2019-02-08 | 56102 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2019-01-08 | 2019-02-09 | 71633 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2019-06-19 | 2020-04-03 | 87054 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2019-12-19 | 2020-03-04 | 101640 |
| KETOROLAC | 0.5% | SOLUTION | Resolved | 2021-04-20 | 2021-06-24 | 137758 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FLOCTAFENINE | 400MG | TABLET | Discontinued | 2018-12-20 | 2022-01-27 | 70197 |
| ETODOLAC | 200MG | CAPSULE | Discontinued | 2018-12-20 | 2019-01-15 | 70188 |
| ETODOLAC | 300MG | CAPSULE | Discontinued | 2018-12-20 | 2019-01-14 | 70191 |
| ERYTHRO-S | 500MG | TABLET | Discontinued | 2017-04-02 | 2017-04-02 | 5060 |
| ERYTHRO-S | 250MG | TABLET | Discontinued | 2020-07-28 | 2020-07-29 | 121300 |
| ERYTHRO-ES | Discontinued | 2018-12-07 | 2018-12-08 | 68904 | ||
| ERYTHRO-ES | 600MG | TABLET | Discontinued | 2020-08-06 | 2020-08-06 | 121825 |
| ERYTHRO-BASE | 250MG | TABLET | Discontinued | 2017-03-28 | 2017-03-28 | 4584 |
| ERYTHRO-BASE | 250MG | TABLET | Discontinued | 2022-04-01 | 2022-04-02 | 157808 |
| DOXEPIN | 100MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65447 |
| DOXEPIN | 10MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65452 |
| DOXEPIN | 25MG | CAPSULE | Discontinued | 2018-10-23 | 2018-10-24 | 65458 |
| DOXEPIN | 50MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65463 |
| DOXEPIN | 75MG | CAPSULE | Discontinued | 2018-10-23 | 2022-01-27 | 65466 |
| DIFLUNISAL | 250MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108364 |
| DIFLUNISAL | 500MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108367 |
| CHLORAX | 2.5MG 5MG | CAPSULE | Discontinued | 2022-01-20 | 2022-01-21 | 153244 |
| AVENTYL | 25MG | CAPSULE | Discontinued | 2018-10-23 | 2022-01-27 | 65435 |
| PHENYTOIN SODIUM | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-12-28 | 60687 |
| MINOCYCLINE | 50MG | CAPSULE | Discontinued | 2017-03-30 | 2018-02-05 | 4731 |